Comparison Genmab (GMAB) with Competitors
Genmab (GMAB) industry is Biotechnology.
Profit Margin
GMAB5.92%
Industry-0.13%
Upside+6.05%
Operating Margin
GMAB25.11%
Industry-2073.25%
Upside+2098.36%
Debt-to-Equity
GMAB94.17%
Industry29.76%
Upside+216.46%
Free Cash Flow Yield
GMAB1.06%
Industry-1.94%
Upside+3.00%
P/E
GMAB40.20
Industry-18.88
Upside+5908.17%
Forward P/E
GMAB15.53
Industry15.43
Upside+0.64%
P/S
GMAB4.14
Industry9.28
Upside-55.36%
P/B
GMAB2.85
Industry4.70
Upside-39.41%